Bristol-Myers Squibb Co (NYSE:BMY)
| 60.30 Delayed Data As of 4:00pm ET |  -0.20 / -0.33%Today’s Change | 56.75 Today|||52-Week Range 69.75 | -2.79% Year-to-Date |
Latest BMY News | Press Releases
Today’s Trading
| Previous close | 60.50 |
| Today’s open | 60.52 |
| Day’s range | 60.30 - 61.13 |
| Volume | 10,157,710 |
| Average volume (3 months) | 8,918,958 |
| Market cap | $136.2B |
Data as of 4:00pm ET, 09/21/2021
Growth & Valuation
| Earnings growth (last year) | -297.94% |
| Earnings growth (this year) | +16.14% |
| Earnings growth (next 5 years) | +5.54% |
| Revenue growth (last year) | +62.62% |
| P/E ratio | NM |
| Price/Sales | 3.29 |
| Price/Book | 3.64 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | +0.35 | +0.73% |
| GSKGlaxoSmithKline | +0.24 | +0.62% |
| NVONovo Nordisk | +2.11 | +2.12% |
| ZTSZoetis Inc | +2.33 | +1.17% |
Data as of 5:34pm ET, 09/21/2021
Financials
| Next reporting date | October 27, 2021 |
| EPS forecast (this quarter) | $1.94 |
| Annual revenue (last year) | $42.5B |
| Annual profit (last year) | -$9.0B |
| Net profit margin | -21.20% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters New York, New York |
Forecasts
